Surface NK receptors and their ligands on tumor cells

被引:230
作者
Moretta, Lorenzo
Bottino, Christina
Pende, Daniela
Castriconi, Roberta
Mingari, Maria Cristina
Moretta, Alessandro
机构
[1] Ist Giannina Gaslini, I-16148 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy
[4] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[5] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
关键词
natural killer cells; cytolytic T lymphocytes; killer Ig-like receptors; HLA-class I molecules; inhibitory receptors; activating receptors; KIR repertoire;
D O I
10.1016/j.smim.2006.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The identification of MHC-class I-specific inhibitory receptors in humans and mice provided a first explanation of why NK cells can kill target cells that have lost or underexpress MHC-class I molecules but spare normal cells. However, the molecular basis of NK-mediated recognition and tumor cell killing revealed a higher degree of complexity. Thus, under pathological conditions, NK cells may express insufficient amounts of triggering receptors and target cells may or may not express ligands for such receptors. Here we briefly illustrate the main NK receptors and their cellular ligands and we delineate the major receptor/ligands interactions leading to NK cell activation and tumor cell lysis. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 108 条
[11]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[12]   Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells [J].
Bottino, C ;
Moretta, L ;
Pende, D ;
Vitale, M ;
Moretta, A .
MOLECULAR IMMUNOLOGY, 2004, 41 (6-7) :569-575
[13]   Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567
[14]   GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J].
Bottino, C ;
Falco, M ;
Parolini, S ;
Marcenaro, E ;
Augugliaro, R ;
Sivori, S ;
Landi, E ;
Biassoni, R ;
Notarangelo, LD ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :235-246
[15]   Cellular ligands of activating NK receptors [J].
Bottino, C ;
Castriconi, R ;
Moretta, L ;
Moretta, A .
TRENDS IN IMMUNOLOGY, 2005, 26 (04) :221-226
[16]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[17]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[18]   TLISA1, A HUMAN T-LINEAGE SPECIFIC ACTIVATION ANTIGEN INVOLVED IN THE DIFFERENTIATION OF CYTO-TOXIC LYMPHOCYTES-T AND ANOMALOUS KILLER CELLS FROM THEIR PRECURSORS [J].
BURNS, GF ;
TRIGLIA, T ;
WERKMEISTER, JA ;
BEGLEY, CG ;
BOYD, AW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1063-1078
[19]   NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J].
Cantoni, C ;
Bottino, C ;
Vitale, M ;
Pessino, A ;
Augugliaro, R ;
Malaspina, A ;
Parolini, S ;
Moretta, L ;
Moretta, A ;
Biassoni, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :787-795
[20]  
Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO